This inventor holds 3 USPTO granted patents. Top assignees: Pharmacia Corporation, Warner-Lambert Company. Active years: 2003-2006.
Company Filing History:
Years Active: 2003-2006
Title: Rhonda Wood: Innovator in Anticoagulant Therapy
Introduction
Rhonda Wood is a notable inventor based in Maryland Heights, MO (US). She has made significant contributions to the field of anticoagulant therapy, holding a total of 3 patents. Her work focuses on developing innovative compounds that can effectively inhibit the coagulation cascade, which is crucial for treating various thrombotic conditions.
Latest Patents
Rhonda Wood's latest patents include the invention of substituted polycyclic aryl and heteroaryl pyrazinones. These compounds are designed to serve as selective inhibitors of serine proteases involved in the coagulation cascade. The inventions aim to provide effective compounds, compositions, and methods for anticoagulant therapy, particularly for the treatment and prevention of thrombotic conditions such as coronary artery and cerebrovascular diseases.
Career Highlights
Throughout her career, Rhonda has worked with prominent companies in the pharmaceutical industry, including Pharmacia Corporation and Warner-Lambert Company. Her experience in these organizations has contributed to her expertise in developing innovative therapeutic solutions.
Collaborations
Rhonda has collaborated with several professionals in her field, including Michael S South and John Joseph Parlow. These collaborations have likely enhanced her research and development efforts, leading to her successful patent applications.
Conclusion
Rhonda Wood is a pioneering inventor whose work in anticoagulant therapy has the potential to impact the treatment of thrombotic conditions significantly. Her innovative patents and collaborations reflect her dedication to advancing medical science.